The Banking and Strategy Initiative

Chillin' out till it needs to be funded

Tag Archives: Novartis

US Mid Week Trading Report: Amazon posts close to $20 Bln in Topline, Apple lets iPad slide, Pharma gets big deal traction in earnings season US:SBUX, US:AMZN, US:AAPL, US:NFLX, US:CAT, US:AZN, US:NVS

More brew from the Seahawk line Seattle’s Best (as an Adjective clause, not just the coffee ) may well be Starbucks yet as it scored another 6% in comparable sales … Continue reading

April 25, 2014

Amylin's Bydureon vs Novo Nordisk's Victoza | Deal Insight

Healthcare’s big week continues almost uninterrupted after the weekend with Amylin’s ByDureon a once a day trateatment it found after Byetta’s licensed sales with Eli Lilly plateaued off at $2.5 … Continue reading

January 30, 2012

Advantage Dealbook: Upending that premium again, Gilead gets HCV portfolio

The culprit of course is another rrich Pharma company saturated with its current mdeicine/ device/service product opr package portfolio. After a J&J bid for Synthes that has  not progressed and … Continue reading

November 21, 2011 · 2 Comments

The Big Pharma rebuilding "decade": Is Big Pharma ready for the competition?

Well frankly, after our efforts to read up and check the air pressure on the Big Pharma machines, we find the restructuring effort in each case expensive and not worth … Continue reading

April 19, 2011 · 2 Comments

Is it Novartis? Is it Kraft? Just the cheese.

It’s not even about Cadbury’s anymore And I am not wondering about the title, just who is the bigger offender in this new twist Nestle: $NSRGY         … Continue reading

January 5, 2010

Archives